Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI 41

Mushroom Intoxication in Türkiye: A Nationwide Cohort Study Based on Demographic Trends, Seasonal Variations, and the Impact of Climate Change on Incidence

Gökçe D. T., Ari D., Ata N., GÖKCAN H., İDİLMAN R., Ülgü M. M., et al.
Turkish Journal of Gastroenterology , vol.36, no.1, pp.61-66, 2025 (SCI-Expanded) identifier identifier

Assessing hepatic steatosis by magnetic resonance in potential living liver donors

Kuru Öz D., Ellik Z., Gürsoy Çoruh A., Adıgüzel M., Gümüşsoy M., Kiremitci S., et al.
Diagnostic and Interventional Radiology , vol.30, no.6, pp.351-356, 2024 (SCI-Expanded) identifier identifier

ASSESSMENT OF THE RELATIONSHIP BETWEEN MRI-BASED INTRAMUSCULAR FAT INDICATING SARCOPENIA IN VARIOUS MUSCLE GROUPS AMONG PATIENTS WITH CHRONIC LIVER DISEASE

Er R. E., Akkaya Z., Ünal S., Kuru Öz D., Çelebi M. M., Gökcan H., et al.
HEPATOLOGY , 2024 (SCI-Expanded) identifier

HEPATIC STEATOSIS IS ASSOCIATED WITH HBSAG CLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION

BODAKÇİ E., KİREMİTCİ S., DUMAN S., MELEKOĞLU ELLİK Z., Gumussoy M., GÜVENİR S. T., et al.
HEPATOLOGY , 2024 (SCI-Expanded) identifier

Recurrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registry

Adali G., Harputluoglu M., Kayhan M. A., Gokce D. T., AKARSU M., Daniscomma N., et al.
JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded) identifier

Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gokce D. T., Gumussoy M., KİREMİTCİ S., Bodakci E., Yilmaz V., et al.
JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded) identifier

A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone

Duman S., Kuru D., Gumussoy M., KİREMİTCİ S., GÖKCAN H., Ulas B., et al.
EUROPEAN RADIOLOGY , vol.34, no.6, pp.3882-3888, 2024 (SCI-Expanded) identifier identifier identifier

Multidrug-Resistant Infections After Liver Transplantation, Etiology and Risk Factors: A Single-Center Experience

Tezcan H., Altunsoy A., Gokce D. T., GÖKCAN H., Ari D., Aydin O., et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION , vol.21, no.12, pp.952-960, 2023 (SCI-Expanded) identifier identifier identifier

Development of metabolic disorders in transplant recipients

Erdemir G., GÖKCAN H., GÜRSOY ÇORUH A., GÜLPINAR B., Ellik Z. M., Gumussoy M., et al.
JOURNAL OF HEPATOLOGY , vol.78, 2023 (SCI-Expanded) identifier

Effect of Pretransplant Sarcopenia on Mortality in Liver Transplant Recipients

Arı D., Dağlı M., GÖKCAN H., Gökçe D. T., Ökten R. S., Aydın O., et al.
Experimental and Clinical Transplantation , vol.21, no.2, pp.123-131, 2023 (SCI-Expanded) identifier identifier

Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience

Karakaya M. F., Er E., Kırımker O., Gümüşsoy M., Bodakçi E., Özercan M., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.2, pp.177-181, 2023 (SCI-Expanded) identifier identifier

Complete Recovery After Immunosuppressive Treatment Change in a Patient With Posttransplant Lymphoproliferative Disorder

Arı D., Turan D., GÖKCAN H., Özdemir M., Kayhan M. A.
Experimental and Clinical Transplantation , vol.21, no.1, pp.76-79, 2023 (SCI-Expanded) identifier identifier

Lymphocyte count and NLR as predictive value for the severity of acute cholangitis

Yeşil B., Çalişkan A., Koşar K., Yüksel M., GÖKCAN H., Tümtürk A., et al.
European Review for Medical and Pharmacological Sciences , vol.27, no.18, pp.8732-8739, 2023 (SCI-Expanded) identifier identifier

Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study

Gumussoy M., Koc O., KARATAŞ G., Ozercan M., Ellik Z., DUMAN S., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.34, no.11, pp.1172-1177, 2022 (SCI-Expanded) identifier identifier identifier

NATURAL DISEASE OUTCOMES IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE: A STUDY WITH PAIRED LIVER BIOPSIES

Gumussoy M., Gokce D. T., Ekelik M., KİREMİTCİ S., Bodakci E., DUMAN S., et al.
HEPATOLOGY , vol.76, 2022 (SCI-Expanded) identifier

Effectiveness of MRI methods in the assessment of hepatic steatosis in living liver donors

KURU ÖZ D., Ellik Z. M., Coruh A. G., ADIGÜZEL M., Gumussoy M., DUMAN S., et al.
JOURNAL OF HEPATOLOGY , vol.77, 2022 (SCI-Expanded) identifier

Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients

Bacaksiz F., GÖKCAN H., Akdogan M., Gokce D. T., Ari D., Gokbulut V., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021 (SCI-Expanded) identifier identifier identifier

Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

AKARSU M., Onem S., TURAN İ., Adali G., Akdogan M., Akyildiz M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.9, pp.712-719, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier identifier

Association between non-alcoholic fatty liver disease and extrahepatic malignancy

Gumussoy M., İDİLMAN R., GÖKCAN H., Gokce D. T., Ulas B. B., Koc O., et al.
JOURNAL OF HEPATOLOGY , vol.75, 2021 (SCI-Expanded) identifier

Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

Degertekin B., DEMİR M., AKARCA U. S., Kani H. T., ÜÇBİLEK E., Yildirim E., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12, pp.883-893, 2020 (SCI-Expanded) identifier identifier identifier identifier

Effects of preoperative endoscopic pneumatic balloon dilatation on postoperative achalasia symptoms after Heller esophageal myotomy plus Dor fundoplication

Gokcan H.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.5, pp.526-529, 2018 (SCI-Expanded) Creative Commons License identifier identifier identifier

Prognostic Utility of Hypokalemia in Cirrhotic Patients

Kaplan M., Ates I., Gokcan H., Kayhan M. A., Kacari S., Akpinar M. Y., et al.
ACTA GASTRO-ENTEROLOGICA BELGICA , no.3, pp.398-403, 2018 (SCI-Expanded) identifier identifier identifier

GASTROINTESTINAL STROMAL TUMOR IN A YOUNG MAN WITH SEVERE HEMATEMESIS : A CASE STUDY

kuzu U. B., Suna N., Torun S., Gokcan H., Oztas E., Odemis B.
GASTROENTEROLOGY NURSING , vol.39, no.5, pp.397-399, 2016 (SCI-Expanded) identifier identifier identifier

Pregabalin: A New Adjunct in Calcineurin Inhibitor Pain Syndrome Treatment

Tasoglu O., Gokcan H., Demir S. O., Yenigun D., Akdogan M., Kacar S.
PROGRESS IN TRANSPLANTATION , vol.26, no.3, pp.224-226, 2016 (SCI-Expanded) identifier identifier identifier

Case of a successful liver transplantation from a living donor with focal nodular hyperplasia

Gokcan H., Akdogan M., Kacar S., Okten R. S., Ozdemir M., Turhan N., et al.
ACTA GASTRO-ENTEROLOGICA BELGICA , vol.79, no.2, pp.262-263, 2016 (SCI-Expanded) identifier identifier identifier

The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C

Gokcan H., Kuzu U. B., Oztas E., Saygili F., Oztuna D., Suna N., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , no.2, pp.156-164, 2016 (SCI-Expanded) identifier identifier identifier

Different bismuth-based therapies for eradicating Helicobacter pylori: Randomized clinical trial of efficacy and safety

Gokcan H., Oztas E., Onal I. K.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , vol.40, no.1, pp.124-131, 2016 (SCI-Expanded) identifier identifier identifier

Predictors of Survival in Hepatocellular Carcinoma Patients

Gokcan H., Savas N., Oztuna D., Moray G., Boyvat F., HABERAL M.
ANNALS OF TRANSPLANTATION , pp.596-603, 2015 (SCI-Expanded) identifier identifier identifier

Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors

Kuzu U. B., Gokcan H., Suna N., Ozdemir M., Yildiz H., Kacar S., et al.
TRANSPLANTATION PROCEEDINGS , no.6, pp.1854-1859, 2015 (SCI-Expanded) identifier identifier identifier

Fractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitis

Gokcan H., Yurtcu E., Selcuk H., Sahin F. I.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , vol.15, no.2, pp.73-77, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier

The Nutritional Risk Screening 2002 tool for detecting malnutrition risk in hospitalised patients: Perspective from a developing country

Gokcan H., Selcuk H., Tore E., Gulseren P., Cambaz H., Saritas S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, pp.718-723, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

What is the impact of Helicobacter pylori density on the success of eradication therapy: A clinico-histopathological study

Onal I. K., Gokcan H., Benzer E., Bilir G., Oztas E.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , vol.37, no.6, pp.642-646, 2013 (SCI-Expanded) identifier identifier identifier

A case of eosinophilic gastritis secondary to ulcerative colitis

Gokcan H., Uruc I., Selcuk H., Savas N., Yilmaz U.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.21, no.1, pp.69-70, 2010 (SCI-Expanded) identifier identifier identifier

Detection of MEFV Gene Mutations in Patients with Inflammatory Bowel Disease

Yurtcu E., Gokcan H., Yilmaz U., ŞAHİN F. İ.
GENETIC TESTING AND MOLECULAR BIOMARKERS , vol.13, no.1, pp.87-90, 2009 (SCI-Expanded) identifier identifier identifier

Total colonic polyp diameter: A marker for the risk of malignancy?

Selcuk H., Korkmaz M., Kanbay M., Tore E., Sumer H., UNAL H. U., et al.
HEPATO-GASTROENTEROLOGY , vol.55, no.84, pp.936-939, 2008 (SCI-Expanded) identifier identifier identifier

Dipeptidyl peptidase IV (DDP IV) in NASH patients

BALABAN H. Y., KORKUSUZ P., Simsek H., Gokcan H., Gedikoglu G., Pinar A., et al.
ANNALS OF HEPATOLOGY , vol.6, no.4, pp.242-250, 2007 (SCI-Expanded) identifier identifier identifier

Malignancy risk of small polyps and related factors

UNAL H. U., Selcuk H., Gokcan H., Tore E., Sar A., Korkmaz M., et al.
DIGESTIVE DISEASES AND SCIENCES , vol.52, no.10, pp.2796-2799, 2007 (SCI-Expanded) identifier identifier identifier

<i>HFE</i> mutations analysis of Turkish patients with nonalcoholic steatohepatitis

Simsek H., BALABAN H. Y., Sumer H., Yilmaz E., Tatar G.
DIGESTIVE DISEASES AND SCIENCES , no.10, pp.1723-1724, 2006 (SCI-Expanded) identifier identifier

Mutations of the HFE gene among Turkish hereditary hemochromatosis patients

Simsek H., BALABAN H. Y., Yilmaz E., Sumer H., Buyukasik Y., Cengiz C., et al.
ANNALS OF HEMATOLOGY , vol.84, no.10, pp.646-649, 2005 (SCI-Expanded) identifier identifier identifier

Bone marrow embolism after bone marrow aspiration and biopsy

Önal I., Sümer H., TUFAN A., Shorbagi A.
AMERICAN JOURNAL OF HEMATOLOGY , vol.78, no.2, pp.158, 2005 (SCI-Expanded) identifier identifier identifier

Frequency of HFE mutations among Turkish blood donors according to transferrin saturation

Simsek H., Sumer H., Yilmaz E., BALABAN H. Y., Ozcebe O., Hascelik G., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.38, no.8, pp.671-675, 2004 (SCI-Expanded) identifier identifier identifier
Articles Published in Other Journals 28

A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis

GÖKCAN H., Oz D., BODAKÇİ E., TUNÇ E., İDİLMAN R.
HEPATOLOGY FORUM , vol.5, no.3, pp.161-164, 2024 (ESCI) identifier identifier identifier

A Brief Communication of Patients of Patients with Homozygous C282Y Mutation-Related Hereditary Hemochromatosis.

GÖKCAN H., Öz d. K., BODAKÇİ E., İDİLMAN R.
Hepatology forum , vol.5, pp.161-164, 2024 (ESCI) identifier identifier

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

Akarsu M., DOLU S., Harputluoglu M., YILMAZ S., Akyildiz M., Gencdal G., et al.
Hepatology Forum , vol.5, no.1, pp.3-6, 2024 (Scopus) Creative Commons License identifier identifier

Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study

AKARSU M., Harputluoğlu M., AKYILDIZ M., GENÇDAL G., DİNÇER D., ADANIR H., et al.
Hepatology forum , vol.5, no.1, pp.3-6, 2024 (ESCI) identifier identifier identifier

Pancreatic metastasis of renal cell carcinoma: case report

Gökcan H.
Journal of Current Hematology & Oncology Research , vol.1, no.4, pp.109-110, 2023 (Peer-Reviewed Journal) Creative Commons License

Hepatoselüler kanser, Güncel yenilikler

GÖKCAN H.
Güncel Gastroenteroloji , vol.25, no.2, pp.75-89, 2023 (Peer-Reviewed Journal)

Post traumatic volvulus: a case report

Gökcan H.
Journal of Comprehensive Surgery , vol.1, pp.60-62, 2023 (Peer-Reviewed Journal)

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.

YILMAZ Y., ZEYBEL M., ADALI G., COŞAR A., SERTESEN E., SÜMER H., et al.
Hepatology forum , vol.4, no.Suppl 1, pp.1-32, 2023 (ESCI) Creative Commons License identifier identifier identifier identifier

The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort

Yaras S., Demir M., Barutcu S., Yildirim A. E., GÜREL S., Ucbilek E., et al.
Hepatology Forum , vol.4, no.3, pp.92-96, 2023 (Scopus) identifier identifier

Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis

Gokce D. T., Ari D., GÖKCAN H., Aydin O., Turhan N., Kayhan M. A.
HEPATOLOGY FORUM , vol.4, no.1, pp.35-36, 2023 (ESCI) Creative Commons License identifier identifier

The changing non-invasive fibrosis index value in patients with hepatitis C treated with direct-acting antiviral agents

Ari D., Gökçe D. T., Gökcan H., Öztürk Ö., Bacaksiz F., Kacar S., et al.
Akademik Gastroenteroloji Dergisi , vol.21, no.3, pp.109-114, 2022 (Peer-Reviewed Journal) Creative Commons License identifier

Characteristics of patients with hepatocellular carcinoma: A multicenter study

Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.
HEPATOLOGY FORUM , vol.3, no.3, pp.71-76, 2022 (ESCI) Creative Commons License identifier identifier identifier identifier

NSAID-associated drug-induced liver injury prior to and following liver transplantation

Gumussoy M., GÖKCAN H., BODAKÇİ E., KİREMİTCİ S., SAVAŞ B., İDİLMAN R.
HEPATOLOGY FORUM , vol.3, no.3, pp.108-109, 2022 (ESCI) identifier identifier

Evaluation of esophageal motor functions in patients diagnosed with primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis

Gokbulut V., Ozturk O., Akdogan M., Kaplan M., GÖKCAN H., Kacar S., et al.
CUKUROVA MEDICAL JOURNAL , vol.47, no.1, pp.21-28, 2022 (ESCI) Creative Commons License Sustainable Development identifier identifier

Our Experience with Patients That Diagnosed Ischemic Colitis in Colonoscopy

Gökbulut V., Kaplan M., Disibeyaz S., Kacar S., Gökcan H., Gökbulut P., et al.
Journal of Contemporary Medicine , vol.12, no.1, pp.38-43, 2022 (Peer-Reviewed Journal) Creative Commons License

HBV/HDV management after liver transplantation: Review

Muhammad H., Zaffar D., Tehreem A., Peng-Sheng T., ŞİMŞEK C., GÖKCAN H., et al.
Journal of Liver Transplantation , 2021 (Peer-Reviewed Journal)

Hepatitis D Infection in Asia: A Perspective From an Endemic Region

GÖKCAN H., İDİLMAN R.
Clinical Liver Disease , vol.18, no.1, pp.26-29, 2021 (Scopus) Sustainable Development identifier identifier

The Prevalence of Metabolic Associated Fatty Liver Disease in The Turkish Population: A Multicenter Study

YILMAZ Y., YILMAZ N., ATEŞ F., KARAKAYA M. F., GÖKCAN H., KAYA E., et al.
Hepatology forum , vol.2, no.2, pp.37-42, 2021 (ESCI) identifier identifier

Gastrointestinal Subepitelyal Lezyonlarda Tedavi ve İzlem Algoritmi Treatment and Monitoring of Gastrointestinal Subepitelial Lesions

ARI D., GÖKCAN H., AKDOĞAN KAYHAN M.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , pp.72-76, 2020 (Non Peer-Reviewed Journal)

Effectiveness of Technetium-99 m monoclonal antibody scintigraphy for the detection of infectious focus in a case series in cirrhotic patients

GÖKCAN H., AKTAŞ A., ÖZTÜRK Ö., SAVAŞ N.
Hepatology forum , vol.2, no.1, pp.75-78, 2020 (ESCI) identifier identifier identifier

Prevalence and characteristics of bone disease in cirrhotic patients

GÖKCAN H., Kayhan M. A., Demir S. O., Kacar S., Cam P., Kaplan M., et al.
HEPATOLOGY FORUM , vol.1, no.2, pp.48-52, 2020 (ESCI) Creative Commons License identifier identifier identifier

Mallory-Weiss Sendromunda Tanı, Klinik Seyir ve Endoskopik Tedavi

Gökcan H.
Endoskopi Gastrointestinal , vol.26, no.2, pp.41-45, 2018 (Peer-Reviewed Journal) Creative Commons License identifier

Primer Biliyer Kolanjit Hastalarında Tedaviye Yanıt Kriterlerinin Değerlendirilmesi

YÜKSEL M., YILDIZ H., AKDOĞAN KAYHAN M., Kacar S., KILIÇ Z. M. Y., ÖZTAŞ E., et al.
Akademik Gastroenteroloji Dergisi , vol.16, pp.24-29, 2017 (Peer-Reviewed Journal) identifier

Primer sklerozan kolanjiti taklit eden otoimmün kolanjiyopati: Vaka sunumu

Akpınar M. Y., Ödemiş B., Kacar S., GÖKCAN H., KUZU U. B.
Akademik Gastroenteroloji Dergisi , 2016 (Peer-Reviewed Journal)

Porcelain Gallbladder

Akpınar M. Y., KAPLAN M., GÖKCAN H., Erkan V., KAYAÇETİN E.
Akademik Gastroenteroloji Dergisi , 2016 (Peer-Reviewed Journal)

Metastases of malignant melanoma to stomach

Kuzu U. B., Suna N., Gokcan H., Abdullazade S., Oztas E., Odemis B.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY , vol.11, no.1, pp.54-55, 2016 (ESCI) Creative Commons License identifier identifier

Hepatit C’li hastalarda ortalama trombosit hacmi ve nötrofil-lenfosit oranının anlamlı fibrozis tanısında etkinliği

KUZU U. B., ÖZTAŞ E., SUNA N., Sırtaş Z., YILDIZ H., Akpınar M. Y., et al.
Akademik Gastroenteroloji Dergisi , 2015 (Peer-Reviewed Journal)

Herediter Hemochromatozis

SÜMER H., ŞİMŞEK H., TATAR G.
Türkiye Klinikleri Journal Of Microbiology-Infection (kronik hepatit özel sayısı) , vol.2, no.3, pp.184-194, 2003 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 111

Histological and clinical disease progression in patients with metabolic associated steatotic liver disease using paired biopsy

ekelik m., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., yılmaz v., et al.
EASL congress 2024, 05 June 2024, (Summary Text)

The impact of tumor budding in patients with hepatocelular carcinoma

Duran o. f., GÖKCAN H., KİREMİTCİ S., YILMAZ V., ÇİFTÇİ A., BODAKÇİ E., et al.
EASL congress 2024, 05 June 2024, (Summary Text)

Requrrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registery

ADALI G., harputluoğlu m., AKDOĞAN KAYHAN M., TURAN D., AKARSU M., DANIŞ N., et al.
EASL congress 2024, 05 June 2024, (Summary Text)

Assessing Hepatic Steatosis by Magnetic Resonance Imaging in Potential Living Liver Donors

Kuru Öz D., Ellik Z., Gürsoy Çoruh A., Gümüşsoy M., Adıgüzel M., Kiremitci S., et al.
AASLD-TASL Hepatology Connect Meeting 2024, İzmir, Turkey, 16 - 17 February 2024, pp.1-2, (Summary Text)

Assesing Hepatic Steatosis by MRI in potential living liver donors

Kuru Öz d., MELEKOĞLU ELLİK Z., GÜRSOY ÇORUH A., GÜMÜŞSOY M., kırımker o. e., GÖKCAN H., et al.
AASLD-TASL hepatology connect meeting 2024, 16 February 2024, (Summary Text)

SAT-519 The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma

DURAN O. F., GÖKCAN H., KİREMİTCİ S., GÜVENİR S. T., YILMAZ V., BODAKÇİ E., et al.
AASLD-TASL hepatology connect meeting, 16 February 2024, (Full Text) identifier

The impact of tumor budding on tumor biology in patients with hepatocellular carcinoma

Duran O. F., GÖKCAN H., KİREMİTCİ S., GÜVENİR S. T., YILMAZ V., BODAKÇİ E., et al.
AASLD-TASL hepatology connect meeting 2024, 16 February 2024, (Summary Text)

Histological and Clinical disease Progression in Patients with Metabolic Dysfuntion associated Steatotic Liver Disease Isinig Paired Biopsy

Ekelik M. M., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., YILMAZ V., et al.
AASLD-TASL hepatology connect meeting 2024, 16 February 2024, (Summary Text)

C282Y mutation in hemochromatosis: Single center experience

BODAKÇİ E., GÖKCAN H., GÜMÜŞSOY M., GÜVENİR S. T., YILMAZ V., KARAKAYA M. F., et al.
AASLD-TASL hepatology connect meeting 2024, 16 February 2024, (Summary Text)

Hepatic steatosis is associated with HbsAg clearnce in patients with chronic hepatitis B infection

BODAKÇİ E., DUMAN S., KİREMİTCİ S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., ER R. E., et al.
AASLD-TASL hepatology connect meeting 2024, 16 February 2024, (Summary Text)

Gastric bronchogenic cyst mimicking pancreatic mucinous cyst

duran o. f., GÖKCAN H., KACAR S., AKDOĞAN KAYHAN M., BOSTANCI E. B.
19. Euroasian Hepatogastroenterology and Surgery, 13 November 2023, (Full Text)

Case series of C282Y mutation in the HFE gene in Turkey: Single-center experience

BODAKÇİ E., GÖKCAN H., güvener t., YILMAZ V., ER R. E., KARAKAYA M. F., et al.
19. Euroasian Hepatogastroenterology and Surgery, 13 November 2023, (Full Text)

Familial NAFLD Cirrhosis Case Series

AKARCA H. T., GÖKCAN H., GÜVENİR S. T., YILMAZ V., İDİLMAN R.
19. Euroasian Hepatogastroenterology and Surgery, 13 November 2023, (Full Text)

noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan Gökçe D., DUMAN S., Ellik Z. M., GÜMÜŞSOY M., et al.
AASLD 2023 congress, 10 November 2023, (Full Text)

Noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan D., DUMAN S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., et al.
AASLD 2023 congress, United States Of America, 10 November 2023, (Summary Text)

NON - INVASIVE FIBROSIS MARKERS FOR ASSESMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA

BODAKÇİ E., KARAKAYA M. F., KURU ÖZ D., Gokce D. T., DUMAN S., Ellik Z. M., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 10 - 14 November 2023, (Summary Text) identifier

development of Metabolic Disorders in Transplant Recepients

Erdemir G., GÖKCAN H., Gürsoy Çoruh A., GÜLPINAR B., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., et al.
EASL Congress 21-24 June 2023, Austria, 21 - 24 June 2023, vol.78, pp.477-478, (Full Text) identifier

development of Metabolik disorders in Liver transplant recepients

Erdemir G., GÖKCAN H., İDİLMAN R.
The 2023 International congress of ILTS ELITA and LICAGE, 03 May 2023, (Full Text)

A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.

DUMAN S., KURU ÖZ D., GÜMÜŞSOY M., KİREMİTCİ S., GÖKCAN H., ÖZERCAN A. M., et al.
AASLD-TASL hepatology connect meeting, 28 - 29 April 2023, (Full Text)

A case of AFP producing cholangiocarcinoma

BODAKÇİ E., GÜMÜŞSOY M., GÜVENİR S. T., KARAKAYA F., GÖKCAN H., İDİLMAN R.
AASLD-TASL hepatology connect meeting, 28 - 29 April 2023, (Full Text)

Development of Metabolic Disorders in Transplant Recepients

erdemir g., GÖKCAN H., GÜRSOY ÇORUH A., GÜMÜŞSOY M., DUMAN S., İDİLMAN R.
AASLD-TASL hepatology connect meeting, 28 - 29 April 2023, (Full Text)

Natural Disease outcome in patients with NAFLDÇ a study with paired liver biopsies

GÜMÜŞSOY M., TURAN D., ekelik m., KİREMİTCİ S., DUMAN S., GÜVENİR S. T., et al.
AASLD-TASL hepatology connect meeting, 28 April 2023, (Full Text)

effect of prognostic tests on disease outcome of alcohol-related liver disease

zengin b. a., GÜMÜŞSOY M., DUMAN S., BODAKÇİ E., ÖZERCAN A. M., ER R. E., et al.
AASLD-TASL hepatology connect meeting, 28 April 2023, (Full Text)

İdentification of risk factors for alcohol relapse in liver transplant patients with alcohol- related liver disease.

TURAN D., GÜNŞAR F., harputluoğlu m., KABAÇAM G., GÖKCAN H., AKARSU M., et al.
EASL Congress 21-24 June 2023, 21 April 2023, (Full Text)

Alkole Bağlı Karaciğer Hastalığında Prognostik Non-İnvasif Testlerin Hastalık Sonucunu Öngörmede Etkinliği

ZENGİN B. A., GÜMÜŞSOY M., DUMAN S., BODAKÇİ E., GÜVENİR S. T., MELEKOĞLU ELLİK Z., et al.
39. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Turkey, 22 November 2022, (Summary Text)

Natural disease Outcome in patients with NAFLD: A study with paired liver biopsy

GÜMÜŞSOY M., Turan Gökçe D., KİREMİTCİ S., BODAKÇİ E., DUMAN S., MELEKOĞLU ELLİK Z., et al.
aasld 2022, 04 November 2022, (Summary Text)

Metabolic Syndrome in liver Transplant recipient

KARA G., GÖKCAN H., İDİLMAN R.
AASLD 2022, 4 - 08 November 2022, (Summary Text)

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patients with hepatitis B virus related cirrhosis

YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., ADANIR H., GÜNDÜZ F. F., et al.
ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022, (Summary Text)

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study

GÖKCAN H., YAPALI S., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., DURAK S., et al.
ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022, (Summary Text)

The effect of clinicopathologic findings of hepatocellüler carcinoma on post transplant survival: a multicenter cohort from TASL Liver transplantation special group

AKYILDIZ M., GENÇDAL G., İNCE V., ZEYTÜNLÜ M., TURAN İ., GÜNŞAR F., et al.
ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022, (Summary Text)

Effectiveness of MRI methods in the asssement of hepatic steatosis in living liver donors

KURU ÖZ D., MELEKOĞLU ELLİK Z., GÜRSOY ÇORUH A., GÜMÜŞSOY M., DUMANLI S., ER R. E., et al.
ınternational Liver congress ILC 2022 (EASL), 22 June 2022, (Summary Text)

Preliminary Results of The effectiveness and safety of Tenofovir alafenamide Fumarate Prophylaxis in HBV individuals, who received Chemo/Immunsupression therapy

GÜNDÜZ F. F., DURAK S., ÜNSAL Y., DEMİR M., MELEKOĞLU ELLİK Z., YILDIRIM A. E., et al.
ınternational Liver congress ILC 2022 (EASL), 22 June 2022, (Summary Text)

Trends and causes of etiology in adult liver transplant patients: multicenter study

AKARSU M., Harputluoğlu M., YILMAZ S., GENÇDAL G., AKYILDIZ M., DİNÇER D., et al.
ınternational Liver congress ILC 2022 (EASL), 22 - 26 June 2022, (Summary Text)

Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416)

GÖKCAN H., YAPALI S., HARPUTLUOĞLU M. M. M., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., et al.
EASL The International Liver Congress, London, Canada, 26 June 2022, (Summary Text)

Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis (SAT421)

YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., GÜZELBULUT F., VATANSEVER S., et al.
EASL The International Liver Congress, London, Canada, 22 June 2022, (Summary Text)

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: A multicenter study

YAPALI S., GÖKCAN H., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., DURAK S., et al.
ILTS 2022, 04 May 2022, (Summary Text)

Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: A multicenter study

YAPALI S., GÖKCAN H., harputluoğlu M., MELEKOĞLU ELLİK Z., GÖKÇEN P., ADANIR H., et al.
AASLD TASL Digital Hepatology Meeting, Turkey, 14 - 15 January 2022, vol.3, pp.4, (Full Text)

Biliary complications and management in liver transplant recipients with duct to duct anastomosis: A single center experience

KARAKAYA M. F., ÇINAR K., ER R. E., KIRIMKER E. O., BALCI D., ÖZERCAN A. M., et al.
AASLD-TASL Digital Hepatology Meeting, 14 January 2022, (Summary Text)

Presentation and outcome of autoimmune hepatitis during pregnancy

örmeci a., DUMAN S., İSTEMİHAN Z., GÖKCAN H., ÇAVUŞ B., ARSLAN K., et al.
AASLD-TASL digital Hepatology Connect, 14 January 2022, (Summary Text)

Real Life Efficacy and tolerability of Tenofovir alafenamide fumarate in patiernts with hepatitis B virus related cirrhosis

YAPALI S., GÖKCAN H., DURAK S., MELEKOĞLU ELLİK Z., VATANSEVER S., ADANIR H., et al.
AASLD-TASL digital Hepatology Connect, 14 April 2022, (Summary Text)

Trends and changes of etiology in adult liver transplant patients: mulitcenter study

AKARSU M., Harputluoğlu M., YILMAZ S., AKYILDIZ M., GENÇDAL G., polat k. y., et al.
AASLD-TASL digital Hepatology Connect, 14 January 2022, (Full Text)

Development of Metabolic Disorders İn Liver Transplant Patients

KARA G., GÖKCAN H., GÜMÜŞSOY M., DUMAN S., İDİLMAN R.
AASLD-TASL digital Hepatology Connect, 14 January 2022, (Summary Text)

The Effect of Clinicopathologic findings of Hepatosellüler carcinoma on posttransplant survival: A multicenter kohort from TASL Liver Transplantation special İnterest group

AKYILDIZ M., GENÇDAL G., İNCE V., Harputluoğlu M., ZEYTÜNLÜ M., KILIÇ M., et al.
AASLD-TASL digital Hepatology Connect, 14 - 16 January 2022, (Full Text)

Efficacy and Safety of Tenofovir alafenamide in hepatitis B virus infected patients with chronic hemodialsis and renal transplantation: a preliminary result

ADANIR H., ÖZER ETİK D., YILDIRIM A. E., YAPALI S., ARI D., GÖKCAN H., et al.
AASLD-TASL digital Hepatology Connect, 14 January 2022, (Summary Text)

Bliary Complications and Management in Liver Transplant Patients with Duct to Duct Anastomotis: Single Center Experience

KARAKAYA M. F., ÇINAR K., ER R. E., KIRIMKER E. O., BALCI D., ÖZERCAN A. M., et al.
AASLD-TASL digital Hepatology Connect, 14 January 2022, (Summary Text)

Tenofovir Alafenamid Fumaratın Hepatit B virüsü ile İlişkili Sirozlu Hastalar ve Post-transplant Hastalarda Gerçek Yaşam Etkinliği ve Tolere Edilebilirliğinin Ön Sonuçları

YAPALI S., GÖKCAN H., HARPUTLUOĞLU M., MELEKOĞLU ELLİK Z., AKARSU M., DURAK S., et al.
38. Ulusal Gastroenteroloji Haftası 16-21 Kasım 2021, Antalya, 16 November 2021, (Summary Text)

Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result

YAPALI S., GÖKCAN H., Harputluoğlu M., MELEKOĞLU ELLİK Z., AKARSU M., ADANIR H., et al.
AASLD 2021 congress, 05 November 2021, (Summary Text)

Karaciğer Donörlerinin Preoperatif Yağlanma Değerlendirilmesinde MRG Yöntemlerinin Etkinliği

Kuru Öz D., Melekoğlu Ellik Z., Gürsoy Çoruh A., Adıgüzel M., Gümüşsoy M., Duman S., et al.
38. Ulusal Gastroenteroloji Haftası, 2021, Antalya, Turkey, 16 October - 21 November 2021, pp.160-161, (Summary Text)

Real Life Efficacy and Tolerability of Tenofovir Alafenamide Fumarate in Patients with Hepatitis B Virus-related Cirrhosis and Liver Transplant Recipients. A-Preliminary Result (798)

YAPALI S., GÖKCAN H., HARPUTLUOĞLU M. M. M., MELEKOĞLU ELLİK Z., AKARSU M., DURAK S., et al.
AASLD the Liver Meeting Digital Experience, United States Of America, 12 November 2021, vol.74, pp.490, (Summary Text)

Efficacy and Safety of TAF in Hepatitis B virus infected patiebts with chronic hemodialiss and renal transplantation: A prelimanry result

ADANIR H., etik d. ö., YILDIRIM A. E., YAPALI S., COŞAR A. M., ARI D., et al.
AASLD 2021 congress, 06 November 2021, (Summary Text)

association. between non-alcoholic fatty liver disease and extrahepatic malignancy

GÜMÜŞSOY M., İDİLMAN R., GÖKCAN H., BODAKÇİ E., özercan m., ER R. E., et al.
EASL gongress 2021, 23 June 2021, (Summary Text)

EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY

ADANIR H., MELEKOĞLU ELLİK Z., YILDIRIM A. E., GÜNDÜZ F. F., GÖKCAN H., YARAŞ S., et al.
AASLD‐TASL Digital Hepatology Connect Meeting, 2021, 15 September 2021, (Summary Text)

Non-alcoholic fatty liver disease and extrahepatic malignancy

Gümüşsoy M., Turan Gökçe D., Ulaş B. B., Koç Ö., Karataş G., Bodakçı E., et al.
AASLD-TASL digital Hepatology Connect, 15 January 2021, (Full Text)

The analysis of liver transplant patients with COVİD-19 infection: a national cohort

KABAÇAM G., TURAN İ., KIYICI M., MELEKOĞLU ELLİK Z., dolu S., Dayangaç M., et al.
AASLD-TASL digital Hepatology Connect, İstanbul, Turkey, 15 - 16 January 2021, vol.2, pp.24-25, (Summary Text)

Direkt Etkili Antiviral Ajanlarla Tedavi Olan Hepatit C Hastalarında Noninvaziv Fibrozis İndeks Değerlerinin Değişimi

ARI D., TURAN GÖKÇE D., GÖKCAN H., BACAKSIZ F., ÖZTÜRK Ö., KACAR S., et al.
37. Ulusal Gastroenteroloji Haftası, Turkey, 25 - 29 November 2020, (Summary Text)

Outcomes following deceased and live donor liver transplantation for the indication of acute liver failure: a multicenter study

TURAN İ., ALADAĞ M., Harputluoğlu M., YILMAZ S., GENÇDAL G., ÖZÇAY F., et al.
The digital İnternational Liver Cogress, 27 August 2020, (Summary Text)

Endoskopik İşlemler İçin Başvuran Hastalarda Hepatit B ve C Enfeksiyonlarının Farkındalık Düzeyi

GÖKCAN H., OZTAŞ E., ÖNAL İ. K.
32. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 25 - 29 November 2015

Groove Pankreatit İki Vaka sunumu

KAÇAR S., ZENGİN N. İ., AYDOĞ G., ÖZER İ., ÖZDEMİR M., ÖLÇÜCÜOĞLU E., et al.
12. Ulusal Hepato Gastroenteroloji Kongresi &3. Ulusal Gastroenteroloji Cerrahisi Kongresi, AFYON, Turkey, 8 - 10 October 2015, pp.129

Splenosis Vaka Bildirimi

KAÇAR S., ÖZDEMİR M., YILDIRIM Ş., KERİMEL İ., GÖKCAN H., UFUK BARIŞ K., et al.
” 12. Ulusal Hepato Gastroenteroloji Kongresi 3. Ulusal Gastroenteroloji&Cerrahisi Kongresi, AFYON, Turkey, 8 - 10 October 2015, vol.128

Fokal noduler hiperplazi içeren canlı vericiden başarılı bir karaciğer nakli olgusu

GÖKCAN H., AKDOĞAN KAYHAN M., KAÇAR S., ÖKTEN R. S., ÖZDEMİR M., TURHAN N., et al.
10. Ulusal hepatoloji Kongresi, İstanbul, Turkey, 27 - 30 May 2015

Karaciğer Nodüllerinin Ayırıcı Tanısında Bilgisayarlı Tomografinin Tanısal Değeri

GÖKCAN H., AKDOĞAN KAYHAN M., KAÇAR S., ÖKTEN R. S., TURHAN N., ÖZDEMİR M., et al.
10. Ulusal hepatoloji Kongresi, İstanbul, Turkey, 27 - 30 May 2015, pp.198

Development of malignancy after liver transplantation a case Series

KAÇAR S., GÖKCAN H., ULAŞ M., AKSOY E., AKDOĞAN KAYHAN M., BOSTANCI E. B., et al.
24th Conference of APASL (March 12-15) 2015 İstanbul, İstanbul, Turkey, 12 - 15 March 2015, vol.9

Noninvazive markers for fibrosis in chronic hepatitis B substitution for biopsy

SAYGILI F., SUNA N., ÖZTAŞ E., GÖKCAN H., KUZU U. B., KILIÇ Z. M. Y., et al.
24th Conference of APASL (March 12-15) 2015 İstanbul, İstanbul, Turkey, 12 - 15 March 2015, vol.9

Predictive value of non invasive serum markers on hepatic fibrosis in chronic hepatitis C patients

GÖKCAN H., ÖZTAŞ E., KUZU U. B., SAYGILI F., SUNA N., AKDOĞAN KAYHAN M., et al.
24th Conference of APASL (March 12-15) 2015 İstanbul, İstanbul, Turkey, 12 - 15 March 2015, vol.9

Calcineurin inhibitor induced pain syndrome in liver transplantPatient

TAŞOĞLU Ö., GÖKCAN H., DEMİR ÖZBUDAK S., YENİGÜN D., AKDOĞAN KAYHAN M., KAÇAR S.
24th Conference of APASL (March 12-15) 2015 İstanbul, İstanbul, Turkey, 12 - 15 March 2015, vol.9

Impact of portal vein thrombosis in the survival of cirrhosis Patients

GÖKCAN H., AKDOĞAN KAYHAN M., KAÇAR S., ÖZTAŞ E., COŞKUN O., SUNA N., et al.
24th Conference of APASL (March 12-15) 2015 İstanbul, İstanbul, Turkey, 12 - 15 March 2015, vol.9

Kronik hepatit C hastalarında noninvazif serum belirteçlerinin karaciğer fibrosis üzerindeki tahmin değeri

GÖKCAN H., KUZU U. B., ÖZTAŞ E., SUNA N., SAYGILI F., AKDOĞAN KAYHAN M., et al.
31. ulusal gastroenteroloji haftası, Antalya, Turkey, 25 - 30 November 2014, pp.175

Kronik hepatit B hastalarında Fibrozisi Biyopsisiz Öngörebilmek Mümkünmü

SAYGILI F., SUNA N., ÖZTAŞ E., GÖKCAN H., KUZU U. B., KILIÇ Z. M. Y., et al.
31. ulusal gastroenteroloji haftası, Antalya, Turkey, 25 - 30 November 2014, pp.175

İnflamatuar Bağırsak Hastalığında Fractalkine Resptör Polimorfizmlerinin Rolü

GÖKCAN H., YURTÇU E., SELÇUK H., KİRAZ B., ŞAHİN F. İ., YILMAZ U.
26. Ulusal Gastroenteroloji Kongresi, Ankara, Turkey, 14 - 18 November 2009

Helicobacter Pylori Tedavisinde Levofloksasinli Protokollerin Karşılaştırılması Ve İn Vitro Levofloksasin Direnci

URUÇ İ., SELÇUK H., GÖKCAN H., ÖCAL S., YILDIRIM E., ALTUN R., et al.
26. Ulusal Gastroenteroloji Kongresi, Ankara, Turkey, 14 - 18 November 2009, vol.20, pp.175

Sefotaksimin Olluşturduğu Geri Dönüşümlü Pansitopeni

ÖCAL S., YILDIRIM E., GÖKCAN H., SELÇUK H., HİLMİOĞLU F., YILMAZ U.
26. Ulusal Gastroenteroloji Kongresi, Ankara, Turkey, 14 - 18 November 2009, vol.20, pp.150

Kronik Böbrek Hastalarında HCV virüs Yükü İle Karaciğer Patolojisi Arasındaki İlişki

GÖKCAN H., CAN S., SELÇUK H., YILMAZ U.
26. Ulusal Gastroenteroloji Kongresi, Ankara, Turkey, 14 - 18 November 2009, vol.20, pp.130

ERCP Kararında MRCP nin Rolü

URUÇ İ., SÜMER H., SAVAŞ N., SELÇUK H., YILMAZ U.
25. Ulusal Gastroenteroloji Kongresi, Adana, Turkey, 12 - 16 November 2008, vol.19, pp.116

Canlıdan Karaciğer Naklinde Donör Karaciğer Biyopsisinin Önemi

SAVAŞ N., BERKİ Z., URUÇ İ., SÜMER H., SELÇUK H., YILMAZ U.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.42

Valproik Asit Kullanımına Bağlı Gelişen akut Pankreatit Bir Olgu Sunumu

GÜNEY T., TAŞKOPARAN M., GÖKCAN H., URUÇ İ., ÖZER B., YILMAZ U.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.104

İnflamatuar Barsak Hastalarında MEFV Gen Mutasyonlarının Belirlenmesi

YURTÇU E., GÖKCAN H., KİRAZLI B., URUÇ İ., SELÇUK H., YILMAZ U., et al.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007

Renal Replasman Tedavisi Gören Son Dönem Böbrek Yetmezlik Hastalarının Nutrisyonel status Değerlendirilemsinde SGD ve MİS Karşılaştırılması

ÖNAL S., ŞAHİN C., BACAKSIZ M., KARANFİL Y., GÖKCAN H., SEZER S., et al.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.39

Karaciğer Transplantasyonu Sonrası Hepatit B Profilaksisinde Hepatit B İmmunglobulin Ve Lamuvidinin Birlikte Kullanımı

SAVAŞ N., SEVMİŞ Ş., URUÇ İ., SÜMER H., SELÇUK H., YILMAZ U., et al.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.11

Mezenterin Soliter Fibröz Tümörü Olgu Sunumu

BAL Z., URUÇ İ., GÖKCAN H., SAVAŞ N., SELÇUK H., YILMAZ U.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.39

Aşırı Yüksek Seviyede Trigliserid Düzeyi İle Başvuran Bir Pankreatit Olgusu ve Tedavisi

ARIN E. B., GÖKCAN H., URUÇ İ., SELÇUK H., SAVAŞ N., YILMAZ U.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.65

Sirotik Şilöz Asit Olgu Sunumu

URUÇ İ., DAL P., GÖKCAN H., SAVAŞ N., SELÇUK H., YILMAZ U.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.71

Ailesel HiperKolesterolemide Canlıdan Karaciğer Transplantasyonu

SAVAŞ N., SÜMER H., URUÇ İ., SELÇUK H., YILMAZ U., HABERAL M.
24. Ulusal Gastroenteroloji Kongresi, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.13

Akut Karaciğer Yetmezliği ile Gelen Primer Hepatik Lenfoma Olgusu

GÖKCAN H., SELÇUK H., AKYÜREK N., AYYILDIZ T., GÜR G., YILMAZ U.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.177

Asemptomatik olarak İleri Yaşa Ulaşmış 54 adet Koledok Taşı

SELÇUK H., ÖCAL S., ÜNAL H. Ü., GÖKCAN H., YILMAZ U.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.159

Kronik Karaciğer Hastalarında İnfeksiyon Odağının Saptanmasında Tc 99M Monoklonal Antikor Sintigrafisinin Yeri

GÖKCAN H., SELÇUK H., AKTAŞ A., ARAS M., SAVAŞ N., ÜNAL H. Ü., et al.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.224

Perkütan endoskopik Gastrostomi 106 Hastanın Retrospektif Analizi

GÖKCAN H., SELÇUK H., ÜNAL H. Ü., KORKMAZ M., TÖRE E., GÜR G., et al.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.13

Ülseratif Kolite Sekonder Eozinofilik Gastrit Olgu Sunumu

GÖKCAN H., SELÇUK H., SAVAŞ N., URUÇ İ., GÜR G., YILMAZ U.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.14, pp.134

Karaciğer Donör Adaylarının Karaciğer Biyopsilerindeki Histolojik Anormallikler

SAVAŞ N., URUÇ İ., SÜMER H., SELÇUK H., GÜR G., YILMAZ U., et al.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.41

Postoperatif safra kaçağı düşünülen hastada kolay bir uygulama

URUÇ İ., GÖKCAN H., SELÇUK H., GÜNDOĞDU H., GÜR G., YILMAZ U.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.260

Hepatoselüler Karsinomalı Hastalarda Sağkalımı Etkileyen Faktörler

GÖKCAN H., SAVAŞ N., ÖZER F., SELÇUK H., GÜR G., YILMAZ U., et al.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Turkey, 4 - 07 November 2006, vol.17, pp.69

Histological abnormalities found on liver biopsies of appearently healtyh potential liver donors

SAVAŞ N., URUÇ İ., DEMİRHAN Ö., SÜMER H., BİLEZİKÇİ B., SELÇUK H., et al.
57th Annual Meeting of the American Association for The Study of Liver Diseases ( 1-October 2006) Boston, BOSTON, United States Of America, 27 - 31 October 2006

Percutaneous Endoscopic Gastrostomy Retrospective Analysis of 106 Patients

GÖKCAN H., SELÇUK H., ÜNAL H. Ü., TÖRE E., KORKMAZ M., GÜR G., et al.
28 th ESPEN Congress. 19-22 October 2006 İstanbul, İstanbul, Turkey, 19 - 22 October 2006

The Prognostic Significance of Serum Cholesterol and Sodium Levels in Cirrhotic Patients

SELÇUK H., ÜNAL H. Ü., HÜDDAM B., BUTROS R., AKÇIL TEMEL M., KORKMAZ M., et al.
13 th UEGW(2005) Copenhagen, COPENHAGEN, Denmark, 15 - 19 October 2005, vol.54, pp.145

The Effect Of Number of Polyps On Development Of Dysplasia

SELÇUK H., SÜMER H., AKÇIL TEMEL M., TORE E., ÜNAL H. Ü., SAR A., et al.
13 th UEGW(2005) Copenhagen, 15 - 19 October 2005, vol.54

An Analysis of 1500 Small colonic Polyps The Histopatholocigal signifinance and possible Parameters For The Assesment of High Risk Status

SELÇUK H., TÖRE E., SÜMER H., ÜNAL H. Ü., SAR A., KORKMAZ M., et al.
13 th UEGW(2005) Copenhagen, COPENHAGEN, Denmark, 15 - 19 October 2005, vol.54

Metabolic Syndrome NASH and Hepatocyte Growth Factor

BALABAN H. Y., TATAR G., SÜMER H., ŞİMŞEK H., US A. D.
13 th UEGW (2005) Copenhagen, COPENHAGEN, Denmark, 15 - 19 October 2005, vol.54

Küçük Ve Dimunitif Poliplerin Lokalizasyonu İle Malignite Gelişim Riski arasındaki İlişki

ÜNAL H. Ü., SELÇUK H., SÜMER H., TÖRE E., DEMİRHAN B., GÜR G., et al.
22. Ulusal Gastroenteroloji Kongresi, Malatya, Turkey, 30 August - 04 September 2005, vol.16, pp.133

Olgu Sunumu Tip2 Diyabetes Mellituslu Hastada Multiple Gastrik Ülsere Neden Olan Candida İnfeksiyonu

AKIN E., SELÇUK H., KANBAY M., KÜNEFECİ G., SÜMER H., YILMAZ U.
22. Ulusal Gastroenteroloji Kongresi, Malatya, Turkey, 30 August - 04 September 2005, vol.16, pp.60

Antibiotik Kullanan Perkütan Endoskopik Gastrostomi açılan Hastada Ayrıca Antibiotik Profilaksisi Gerekirmi

SELÇUK H., SÜMER H., ÜNAL H. Ü., KORKMAZ M., ERDEM İ., ARIN B., et al.
22. Ulusal Gastroenteroloji Kongresi, Malatya, Turkey, 30 August - 04 September 2005, vol.16, pp.152

Multiple Poliplerin Total Büyüklüğünün Yüksek Riskli Histolojiye Etkisi

SELÇUK H., TÖRE E., SÜMER H., ÜNAL H. Ü., YELOĞLU H. O., BİLEZİKÇİ B., et al.
22. Ulusal Gastroenteroloji Kongresi, Malatya, Turkey, 30 August - 04 September 2005, vol.16, pp.34

Is Prophylactic Antibiotic Theraphy Before Percutenous Endoscopic Gastrostomy Procedure Necessary In Patients Who Are Already On Antibiotic Treatment

SELÇUK H., SÜMER H., ÜNAL H. Ü., KORKMAZ M., KANBAY M., YILMAZ U., et al.
27th ESPEN Congress (27-30 August 2005) Belgium, Belgium, 27 - 30 August 2005, vol.24

NASH Hastalarında H63D Mutasyonu ve Hepatik Demir Birikiminin Değerlendirilmesi

SÜMER H., ŞİMŞEK H., YILMAZ E., BALABAN H. Y., SÖKMENSÜER C., GEDİKOĞLU M. G., et al.
I. Hepatogastroenteroloji Kongresi, Ankara, Turkey, 7 - 10 October 2004, pp.43

CD26 NASH Patogenezini Kontrol Ediyor olabilir mi

BALABAN H. Y., KORKUSUZ P., ŞİMŞEK H., SÜMER H., GEDİKOĞLU M. G., PINAR A., et al.
I. Hepatogastroenteroloji Kongresi, Ankara, Turkey, 7 - 10 October 2004, pp.44

Is CD 26 Dipeptidyl Peptidase IV A Novel Candidate for Controlling NASH Pathogenesis

BALABAN H. Y., KORKUSUZ P., ŞİMŞEK H., SÜMER H., GEDİKOĞLU M. G., PINAR A., et al.
12 th UEGW (25-29 Sep 2004) Prague, Prag, Czech Republic, 25 - 29 September 2004, vol.53

Evaluation H63D Mutation and Hepatic Iron Content in Turkish Patient with non Alcoholic Steatohepatitis

SÜMER H., ŞİMŞEK H., YILMAZ E., BALABAN H. Y., SÖKMENSÜER C., GEDİKOĞLU M. G., et al.
Annual Meeting at Digestive Disease Week (DDW) (15-20 May 2004) New Orleans, Louisiana, ABD, Louisiana, United States Of America, 15 - 20 May 2004, vol.126, pp.758-759

Herediter hemokromatozis hastalarının HFE genlerinin sekans analizi

ŞİMŞEK H., YILMAZ E., BALABAN H. Y., SÜMER H., ÖZCEBE O. İ., HASÇELİK A. G., et al.
20. Ulusal Gastroenteroloji Kongresi, KUŞADASI, Turkey, 30 September - 05 October 2003, pp.143

Türk Herediter Hemokromatozis Hastalarında HFE Gen Mutasyonu

ŞİMŞEK H., BALABAN H. Y., YILMAZ E., SÜMER H., TATAR G.
19. Ulusal Gastroenteroloji Kongresi, Antalya, Turkey, 1 - 06 October 2002, pp.63

Nötropenik Bir Hastada Amfoterisin B ye Yanıt veren Sistemik Fuzaryozis Bir olgu sunumu

ÜLGER Z., ARIKAN AKDAĞLI S., SÜMER H., BERBEROĞLU Z., HASÇELİK A. G., UZUN Ö.
30. Türk Mikrobioloji Kongresi, Antalya, Turkey, 30 September - 05 October 2002

Frequency of H63D mutation in HFE gene of Turkish patients with hereditary hemochromatosis

ŞİMŞEK H., SÜMER H., YILMAZ E., BALABAN H. Y., ÖZCEBE O. İ., HASÇELİK A. G., et al.
Annual Meeting at Digestive Disease Week (DDW) (19-22 May 2002) San Francisco, California, ABD, California, United States Of America, 19 - 22 May 2002, vol.122

Genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey

ŞİMŞEK H., SÜMER H., YILMAZ E., BALABAN H. Y., ÖZCEBE O. İ., HASÇELİK A. G., et al.
Annual Meeting at Digestive Disease Week (DDW) (19-22 Mayıs 2002) San Francisco, California, ABD, California, United States Of America, 19 - 22 May 2002, vol.123, pp.61

Hacettepe Üniversitesi Kan Bankası Donörlerinde Hemokromatozis Gen Taraması

ŞİMŞEK H., SÜMER H., YILMAZ E., BALABAN Y., ÖZCEBE O. İ., HASÇELİK A. G., et al.
18. Ulusal Gastroenteroloji Kongresi, Antalya, Turkey, 25 - 30 October 2001, pp.52
Metrics

Publication

183

Publication (WoS)

46

Publication (Scopus)

44

Citation (WoS)

288

H-Index (WoS)

10

Citation (Scopus)

131

H-Index (Scopus)

7

Citation (Scholar)

7

H-Index (Scholar)

1

Citation (TrDizin)

7

H-Index (TrDizin)

1

Citation (Sum Other)

7

Open Access

13
UN Sustainable Development Goals